Ankerstar Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Ankerstar Wealth's AMPH Position: Q3 2026 in Review
Ankerstar Wealth opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 8 shares worth $206. The stake represents ﹤0.01% of the portfolio and ranks #932 among its holdings. This is a return to the name: Ankerstar Wealth previously reported a position in AMPH as recently as Q4 2025.
Ankerstar Wealth first reported a position in AMPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $402 in Q4 2025. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Ankerstar Wealth held 8 shares of Amphastar Pharmaceuticals worth $206 as of Q3 2026.
- Amphastar Pharmaceuticals was a new Ankerstar Wealth position in Q3 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #932 holding.
- Ankerstar Wealth first reported a position in Amphastar Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- Ankerstar Wealth's Amphastar Pharmaceuticals position peaked at $402 in Q4 2025.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.